STERIS PLC
Закрыт
СекторЗдравоохранение
206.68 1.88
Обзор
Изменение цены акций
24 ч
Мин.
202.11
Макс.
208.46
Доход | 26M 220M |
|---|---|
Продажи | 92M 1.6B |
P/E Средняя по отрасли | 25.239 50.958 |
Прибыль на акцию | 2.83 |
Дивидендная доходность | 1.21 |
Рентабельность продаж | 13.869 |
Сотрудники | 17,937 |
EBITDA | 411M 680M |
Рекомендации | Покупка |
|---|---|
Прогноз на 12 месяцев | +40% upside |
Дивидендная доходность Средняя по отрасли | 1.21% 2.41% |
|---|---|
Следующий отчет о доходах | 5 авг. 2026 г. |
Дата следующей выплаты дивидендов | 26 июн. 2026 г. |
Следующая эксдивидендная дата | 3 сент. 2026 г. |
Рыночная капитализация | -1.3B 20B |
|---|---|
Предыдущая цена открытия | 204.8 |
Предыдущая цена закрытия | 206.68 |
Новостные настроения
By Acuity
50%
50%
146 / 342 Рейтинг в Healthcare
STERIS PLC График
Прошлые результаты не являются надежным индикатором будущих результатов.
О компании STERIS PLC
STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.